Supriya Lifescience's Stock Reaches All-Time High, Outperforms Sector and Sensex

Nov 20 2024 09:20 AM IST
share
Share Via
Supriya Lifescience, a midcap pharmaceutical company, has reached an all-time high stock price of Rs. 704.35 on November 20, 2024. With a 'Buy' call from MarketsMojo and consistent growth, the company has outperformed the sector by 5.09% and the Sensex by 178.84% in the past year.

Supriya Lifescience, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On November 20, 2024, the company's stock price reached an all-time high of Rs. 704.35, which is a significant milestone for the company.

According to MarketsMOJO, a leading stock market analysis platform, Supriya Lifescience's stock is a 'Buy' call. This is a positive indication for investors looking to invest in the pharmaceutical industry.

The company's stock has been performing exceptionally well, outperforming the sector by 5.09% on the day of the all-time high. This is a clear indication of the company's strong financials and growth potential.

In the past three days, Supriya Lifescience's stock has been on a consecutive gain, rising by 12%. This is a remarkable feat and showcases the company's consistent growth in the market.

On the day of the all-time high, the stock opened with a gain of 2%, indicating a strong demand for the company's shares in the market. The stock also touched an intraday high of Rs. 704.35, which is an 8.45% increase from the previous day's closing.

Supriya Lifescience's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This is a positive sign for investors as it indicates a strong upward trend in the company's stock price.

In the past year, Supriya Lifescience's stock has outperformed the Sensex by a significant margin, with a 178.84% increase compared to Sensex's 17.91% performance. This further highlights the company's strong performance and growth potential.

With its recent all-time high and positive performance, Supriya Lifescience is definitely a company to watch out for in the pharmaceutical industry. Its consistent growth and strong financials make it a promising investment opportunity for investors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News